Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Genetics Institute's recombinant factor IX submitted for approval

Sep. 6, 1996

Monoclonal antibody for thrombotic disorders from Teijin

Sep. 6, 1996

Roche and Genentech prepare prodrugs of fibrinogen antagonist

Sep. 6, 1996

Bayer's new cGMP PDE inhibitors

Sep. 6, 1996

Hisamitsu describes platelet aggregation inhibitors

Sep. 6, 1996

Antiplatelet agents described by Kissei

Aug. 30, 1996

TxA2/PGH2 antagonists described by Terumo

Aug. 30, 1996

Fibrinogen antagonists claimed by Thomae

Aug. 30, 1996

Fibrinogen antagonists from Nippon Steel

Aug. 30, 1996

Glaxo Wellcome claims fibrinogen antagonists

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.